Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Staffan Ohlsson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lakartidningen|April 15, 2006
[Waran following thrombolysis with Actilyse]Staffan Ohlsson, Ylva Böttiger
Lakartidningen|August 23, 2006
[Triptans and stroke]Staffan Ohlsson, Anders Helldén
British Journal of Clinical Pharmacology|September 19, 2007
Noscapine may increase the effect of warfarinStaffan Ohlsson, Lennart Holm, Olle Myrberg, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3Mia Sandberg Lundblad, Staffan Ohlsson, Peter Johansson, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteersR Michael Baldwin, Staffan Ohlsson, Rasmus Steen Pedersen, et al.
European Journal of Clinical Pharmacology|July 26, 2008
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjectsStaffan Ohlsson Rosenborg, Jessica Mwinyi, Maria Andersson, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 24, 2015
ISPyB for BioSAXS, the gateway to user autonomy in solution scattering experimentsAlejandro De Maria Antolinos, Petra Pernot, Martha E Brennich, et al.
Journal of Synchrotron Radiation|June 15, 2013
Upgraded ESRF BM29 beamline for SAXS on macromolecules in solutionPetra Pernot, Adam Round, Ray Barrett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lakartidningen|April 15, 2006
[Waran following thrombolysis with Actilyse]Staffan Ohlsson, Ylva Böttiger
Lakartidningen|August 23, 2006
[Triptans and stroke]Staffan Ohlsson, Anders Helldén
British Journal of Clinical Pharmacology|September 19, 2007
Noscapine may increase the effect of warfarinStaffan Ohlsson, Lennart Holm, Olle Myrberg, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3Mia Sandberg Lundblad, Staffan Ohlsson, Peter Johansson, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteersR Michael Baldwin, Staffan Ohlsson, Rasmus Steen Pedersen, et al.
European Journal of Clinical Pharmacology|July 26, 2008
Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjectsStaffan Ohlsson Rosenborg, Jessica Mwinyi, Maria Andersson, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 24, 2015
ISPyB for BioSAXS, the gateway to user autonomy in solution scattering experimentsAlejandro De Maria Antolinos, Petra Pernot, Martha E Brennich, et al.
Journal of Synchrotron Radiation|June 15, 2013
Upgraded ESRF BM29 beamline for SAXS on macromolecules in solutionPetra Pernot, Adam Round, Ray Barrett, et al.
Pageof 1